Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK
Markus Borner, Dieter Koeberle, Roger von Moos, et al.·2008·Annals of Oncology